IPP Bureau
Evonik invests in US-based 3D screen printing technology firm Laxxon Medical
By IPP Bureau - March 07, 2022
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
Arctoris and Evariste Technologies form JV to treat non-small cell lung cancer
By IPP Bureau - March 07, 2022
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
Elixirgen Therapeutics and Taisho Pharmaceutical tie-up to cure ageing-associated diseases
By IPP Bureau - March 07, 2022
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Bone Biologics enters into supply agreement with MTF Biologics for demineralized bone matrix
By IPP Bureau - March 07, 2022
This supply agreement provides material for the company’s planned 30-patient pilot study, and later for its planned U.S. pivotal study in spine fusion patients
Lupin signs Mary Kom for its Shakti campaign promoting heart health
By IPP Bureau - March 07, 2022
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
NATCO launches first generic version of Revlimid in the US
By IPP Bureau - March 07, 2022
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
Aurobindo Pharma Foundation dedicates mini-lift irrigation scheme
By IPP Bureau - March 06, 2022
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
Kilitch Drugs earmarks Rs. 100 crore as part of its expansion
By IPP Bureau - March 06, 2022
The company plans to establish a state-of-the-art greenfield pharma facility with a total of 4-6 manufacturing units in different therapeutics categories to cater to domestic and export markets
Datar Cancer Genetics partners with Kokilaben Hospital to offer advanced cancer tests
By IPP Bureau - March 06, 2022
A simple blood test detects over 30 types of cancers
USFDA approves expanded use of Bristol Myers Opdivo
By IPP Bureau - March 06, 2022
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
Healthium collaborates with Abhinav Bindra to treat sports injuries
By IPP Bureau - March 06, 2022
According to an Injury Surveillance Report by NCA last year, 14.75 % of players sustained shoulder injuries, 13.11% of players sustained knee injuries and almost 74 % players suffer from career-threatening Anterior Cruciate Ligament (ACL) injuries in the 1st two years of return to sport
Sir H.N. Reliance Foundation Hospital performs complete robotic gastric bypass surgery
By IPP Bureau - March 06, 2022
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
Johnson & Johnson Vision Care receives USFDA approval for drug-eluting contact lens
By IPP Bureau - March 06, 2022
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.
By IPP Bureau - March 06, 2022
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
Evonik expands production of plant-derived cholesterol in Germany
By IPP Bureau - March 06, 2022
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
